This article has been cited by
1Early treatment outcome of bedaquiline plus optimised background regimen in drug resistant tuberculosis patients
Sandip V. Barvaliya,Mira K. Desai,Jigar R. Panchal,Rajesh N. Solanki
Indian Journal of Tuberculosis.2020;67(2)222
2Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt
Mohsen A. Gadallah,Alaa Mokhtar,Mervat Rady,Essam El-Moghazy,Magdy Fawzy,Sahar Khalil Kandil
Journal of the Formosan Medical Association.2016;115(11)997
3Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
Malaisamy Muniyandi,Rajeswari Ramachandran
Expert Opinion on Pharmacotherapy.2017;18(13)1301
4Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies
Kelemu Tilahun Kibret,Yonatan Moges,Peter Memiah,Sibhatu Biadgilign
Infectious Diseases of Poverty.2017;6(1)1301
5An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis
Mayara Lisboa Bastos,Zhiyi Lan,Dick Menzies
European Respiratory Journal.2017;49(3)1600803
6Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
Kefyalew Addis Alene,Archie C A Clements,Emma S McBryde,Ernesto Jaramillo,Knut Lönnroth,Debebe Shaweno,Amelia Gulliver,Kerri Viney
Journal of Infection.2018;77(5)357
7Mimickers of Hill-Sachs Lesions
Allison Herring,Derik L. Davis
Canadian Association of Radiologists Journal.2020;77(5)084653711989575
8Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Jia Yin,Jinqiu Yuan,Yanhong Hu,Xiaolin Wei,Pere-Joan Cardona
PLOS ONE.2016;11(3)e0150511
9Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China
Caihong Xu,Yu Pang,Renzhong Li,Yunzhou Ruan,Lixia Wang,Mingting Chen,Hui Zhang
Journal of Infection.2018;76(4)348
10Cigarette Smoking Impairs Human Pulmonary Immunity toMycobacterium tuberculosis
Seónadh M. O’Leary,Michelle M. Coleman,Wui Mei Chew,Colette Morrow,Anne Marie McLaughlin,Laura E. Gleeson,Mary P. O’Sullivan,Joseph Keane
American Journal of Respiratory and Critical Care Medicine.2014;190(12)1430
11Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China
Xubin Zheng,Rongrong Zheng,Yi Hu,Jim Werngren,Lina Davies Forsman,Mikael Mansjö,Biao Xu,Sven Hoffner
Antimicrobial Agents and Chemotherapy.2016;60(8)4786
12Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions
A.K. Janmeja,Deepak Aggarwal,Ruchika Dhillon
Indian Journal of Tuberculosis.2018;65(2)135
13Efficacy and effect of free treatment on multidrug-resistant tuberculosis
Experimental and Therapeutic Medicine.2016;11(3)777
14Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis
Joel Philip Samuels,Aashna Sood,Jonathon R. Campbell,Faiz Ahmad Khan,James Cameron Johnston
Scientific Reports.2018;8(1)777
15Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India
Dina Nair,Pooranaganga D. Navneethapandian,Jaya Prasad Tripathy,Anthony D. Harries,Joel S. Klinton,Basilea Watson,Gomathi N. Sivaramakrishnan,Devarajulu S. Reddy,Lakshmi Murali,Mohan Natrajan,Soumya Swaminathan
Transactions of The Royal Society of Tropical Medicine and Hygiene.2016;110(9)534
16Study of factors influencing response and outcome of Cat-IV regimen in MDRTB patients
Arun Kumar Yadav,Ashok Kumar Mehrotra,S.P. Agnihotri,Shivani Swami
Indian Journal of Tuberculosis.2016;63(4)255
17Reactions to Antituberculous Drugs and Desensitization Treatment
Josefina Cernadas,Eduardo Cernadas
Current Treatment Options in Allergy.2019;6(4)493